<code id='19B23490EB'></code><style id='19B23490EB'></style>
    • <acronym id='19B23490EB'></acronym>
      <center id='19B23490EB'><center id='19B23490EB'><tfoot id='19B23490EB'></tfoot></center><abbr id='19B23490EB'><dir id='19B23490EB'><tfoot id='19B23490EB'></tfoot><noframes id='19B23490EB'>

    • <optgroup id='19B23490EB'><strike id='19B23490EB'><sup id='19B23490EB'></sup></strike><code id='19B23490EB'></code></optgroup>
        1. <b id='19B23490EB'><label id='19B23490EB'><select id='19B23490EB'><dt id='19B23490EB'><span id='19B23490EB'></span></dt></select></label></b><u id='19B23490EB'></u>
          <i id='19B23490EB'><strike id='19B23490EB'><tt id='19B23490EB'><pre id='19B23490EB'></pre></tt></strike></i>

          hotspot

          hotspot

          author:knowledge    Page View:1
          JUUL store sign -- health coverage from STAT
          Stephanie Keith/Getty Images

          Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes.

          Beginning in 2018, Juul executives, including the company’s CEO, discussed six- and seven-figure partnerships with civil rights organizations, one of which would have seen it send as much as $7 million to Sharpton’s group, according to internal emails and documents that were released this week as part of a legal settlement with the state of North Carolina.

          advertisement

          It’s not clear how much the company ultimately spent on the partnerships.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more
          At ASCO, AstraZeneca reports strong data for breast cancer drug
          At ASCO, AstraZeneca reports strong data for breast cancer drug

          ThefuturelooksevenbrighterfortheblockbusterEnhertu,showcasedhereatASCO.ADAMFEUERSTEIN/STATCHICAGO—Th

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Why getting cancer drugs just got harder for rural patients

          AdobeIrecentlystartedapatientwithmetastatictriple-positivebreastcancerpatientonatargetedtherapyregim